| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 31 |
| 1 | ALBUTEROL SULFATE | 22 |
| 2 | ERGOCALCIFEROL | 20 |
| 3 | OMALIZUMAB | 14 |
| 4 | OMEPRAZOLE | 13 |
| 5 | OMEPRAZOLE MAGNESIUM | 13 |
| 6 | ACETAMINOPHEN | 12 |
| 7 | ADALIMUMAB | 12 |
| 8 | EPINEPHRINE | 12 |
| 9 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATROPA BELLADONNA AND OPIUM | 1 | 0.0833 |
| 1 | ADALIMUMAB-RYVK | 2 | 0.0018 |
| 2 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 2 | 0.0018 |
| 3 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 1 | 0.0017 |
| 4 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 5 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 6 | PSYLLIUM HUSK | 2 | 0.0015 |
| 7 | OLANZAPINE AND SAMIDORPHAN L-MALATE | 2 | 0.0012 |
| 8 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 9 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 31 |
| 1 | Corticosteroid [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 3 | Benzodiazepine [EPC] | 18 |
| 4 | Anti-IgE [EPC] | 14 |
| 5 | Proton Pump Inhibitor [EPC] | 14 |
| 6 | Catecholamine [EPC] | 12 |
| 7 | Osmotic Laxative [EPC] | 12 |
| 8 | alpha-Adrenergic Agonist [EPC] | 12 |
| 9 | beta-Adrenergic Agonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Semifluorinated Alkane [EPC] | 2 | 0.0009 |
| 2 | Pyrethroid [EPC] | 1 | 0.0006 |
| 3 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 5 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 6 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 6 | 0.0002 |
| 8 | RNA Synthetase Inhibitor Antibacterial [EPC] | 3 | 0.0002 |
| 9 | Sympathomimetic-like Agent [EPC] | 6 | 0.0002 |